CHECKPOINTPharmaceuticals
Checkpoint Trends Ltd — PE Ratio & Valuation Analysis
₹46.99
-4.99%
Current P/E38.20xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E1251.3x96.9% below avg
⚠️
20.2% Premium to Industry
CHECKPOINT P/E 38.20x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹0.05 | ₹114 | 2285.2x |
| 2024 | ₹0.06 | ₹13 | 217.5x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Checkpoint Trends Ltd Valuation
Checkpoint Trends Ltd (CHECKPOINT) currently trades at 38.20x earnings. The Pharmaceuticals sector average PE is 31.77x. CHECKPOINT commands a premium, reflecting high growth expectations. Historically, CHECKPOINT has traded at an average PE of 1251.3x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
9.17%
Dividend Yield
0.00%
More on Checkpoint Trends Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.